More News

Topcon, RadiusXR, and Glaukos Team Up to Launch Inspire VR Perimeter Headset

Topcon Healthcare, RadiusXR, and Glaukos announced March 11 that they are teaming up to launch RadiusXR’s new wearable vision testing platform, Inspire. The companies said the partnership capitaliz...

Optos Unveils MonacoPro Ultra-Widefield Retinal Imager with SD-OCT

Optos, a division of Nikon, announced Feb. 14 the launch of the MonacoPro, its next-generation ultra-widefield scanning laser ophthalmoscope with integrated spectral domain optical coherence tomogr...

PDUFA Dates for Ophthalmic Drug Candidates

The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.

Select US FDA Approvals and Clearances in February 2025

There was one US FDA clearance through the ophthalmic device division using the 510(k) pathway in February 2025, according to the agency’s database. New World Medical gained clearance of its Via360...

Retina Surgeons Ready for Alcon to Make a Splash with Unity VCS

Alcon looks ready to shake up the retinal treatment device market with the launch of the Unity VCS later in 2025. Anytime the world’s number one manufacturer of vitreoretinal surgical systems intro...

US FDA Accepts NDA for Glaukos’ Epioxa for Epi-On Crosslinking Therapy

Glaukos, of Aliso Viejo, California, reported Feb. 24 that the US FDA had accepted its new drug application for Epioxa, an epi-on version of the company’s iLink corneal crosslinking therapy, for th...

Chinese Regulators Approve Zeiss’ VisuMax 800 with SMILE Pro Software

Germany’s Carl Zeiss Meditec announced Feb. 26 that the National Medical Products Administration in China had approved its updated VisuMax 800 femtosecond refractive laser and related SMILE Pro sof...

Clinical Trial Updates for Ophthalmic Candidates, March 2025

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

New Arkansas Law Reins in Vision Care Insurers’ Influence over ODs

Optometrists in Arkansas celebrated a legislative victory on Feb. 25 when Gov. Sarah Huckabee Sanders signed into law HB 1353, which supporters say will allow ODs in the state to receive more fair ...

Medicare Physician Fee Cut Won’t be Rolled Back in March

US House members on March 9 dropped language from a stopgap funding bill that would have rolled back the 2.83 percent cut in Medicare reimbursement for doctors that went into effect Jan. 1. The mov...

Deerfield Sues Alcon over Latest Moves to Prevent Aurion IPO

Deerfield Management has filed a lawsuit against an Alcon subsidiary, seeking to prevent Alcon from interfering with Aurion Biotech’s ability to launch an initial public offering. The lawsuit, file...

Study of Corneal Stem Cell Transplant Shows Vision Restored After Injury

A clinical study of patients with irreversible corneal injury, published March 4 in Nature Communications, showed that transplanted epithelial stem cells from their healthy eyes restored at least p...

Early Study Shows Promise for Head-Mounted Retinal Surgery Robot

Researchers at the University of Utah’s John A. Moran Eye Center and John and Marcia Price College of Engineering reported Feb. 19 that they have collaborated to create a new robotic surgery device...

New World Medical Gains US Clearance for the Via360 Viscodilation System for Glaucoma

New World Medical announced Feb. 18 that it had received 510(k) clearance from the US FDA for its Via360 glaucoma surgical system. The Rancho Cucamonga, California, company said the device would be...

Emerging Companies Pursuing Ophthalmic Indications, March 2025

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

Weekly Corporate and Surgeon Poll, March 2025

BVI Leads Latest Ophthalmic Fundraising with $1 Billion in Strategic Capital

BVI Medical led recent ophthalmic fundraising efforts with $1 billion in strategic capital, raised from owner TPG and new investors, to continue expanding globally. Financing announced in the past ...

March 2025 Ophthalmic News Briefs

Alcon announced the US launch Feb. 24 of its Systane Pro Preservative-Free (PF) over-the-counter eye drops for dry eye. The company said Systane Pro PF is the longest lasting eye drop in the Systan...